A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.

Current pharmaceutical design

Volumn 18, Issue 32, 2012, Pages 5131-5140

  Zuardi, Antonio Waldo ^a   Crippa, Jose Alexandre S ^b   Hallak, Jaime E C ^b   Bhattacharyya, Sagnik ^b   Atakan, Zerrin ^b   Martin Santos, Rocio ^b   McGuire, Philip K ^b   Guimarães, Francisco Silveira ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL; NEUROLEPTIC AGENT;

ANIMAL; BRAIN; CLINICAL TRIAL (TOPIC); DRUG EFFECT; HUMAN; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; RAT; REVIEW;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CANNABIDIOL; CLINICAL TRIALS AS TOPIC; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; RATS;

EID: 84870833786     PISSN: None     EISSN: 18734286     Source Type: Journal    
DOI: None     Document Type: Review

References (0)